08045800513
Send Inquiry
Send InquiryVoglibose 0.3 mg & Metformin 500 mg (SR)
MOQ : 15-30 Boxes
Voglibose 0.3 mg & Metformin 500 mg (SR) Specification
- Drug Type
- Specific Drug
- Ingredients
- Glimepride 2 mg + Pioglitazone 30 mg (SR)
- Physical Form
- Tablets
- Function
- Other
- Recommended For
- Type II Diabetes
Voglibose 0.3 mg & Metformin 500 mg (SR) Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- Blister, 10*10 Packing
- Main Export Market(s)
- Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Voglibose 0.3 mg & Metformin 500 mg (SR)
Voglibose 0.3 mg & Metformin 500 mg (SR) tablets are a carefully formulated combination therapy designed to help manage Type II Diabetes effectively. These tablets combine the benefits of Voglibose for regulating blood sugar after meals and Metformin in sustained-release form to provide long-lasting glucose control. Suitable for adults and aged individuals, the medication supports overall glycemic balance and promotes optimal health. Manufactured with precision, the tablets are of the highest quality and align with specific drug standards. This combination is ideal for diabetic patients seeking a reliable solution for improving postprandial glucose levels and maintaining consistent blood sugar levels throughout the day.
FAQs of Voglibose 0.3 mg & Metformin 500 mg (SR):
Q: What is the primary use of this product?
A: Voglibose 0.3 mg & Metformin 500 mg (SR) is recommended for managing Type II Diabetes by controlling blood sugar levels.Q: Who can take these tablets?
A: These tablets are suitable for adults and aged individuals diagnosed with Type II Diabetes.Q: What is the advantage of a sustained-release (SR) formulation?
A: The sustained-release form ensures prolonged and consistent glucose control throughout the day.Q: How does Voglibose function in this combination?
A: Voglibose helps in managing postprandial (after-meal) blood sugar levels by slowing down carbohydrate absorption.Q: Are these tablets supplied internationally?
A: Yes, this product is available for export as well as local supply.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Diabetic Tablets Category
Gliclazide 80 Mg & Metformin 500 Mg
Minimum Order Quantity : 1530 Boxes
Recommended For : Type 2 diabetes
Function : Other
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Drug Type : Specific Drug
Glimperide & Metformin Combinations
Minimum Order Quantity : 1530 Boxes
Recommended For : Management of Type 2 diabetes (NIDDM)
Function : Other
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Drug Type : Specific Drug
Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg
Minimum Order Quantity : 1530 Boxes
Recommended For : 3rd line treatment for Type 2 Diabetes Mellitus, when all other treatment fails
Function : Other
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Drug Type : Specific Drug
Metformin,Glimperide & Atorvastatin Combination
Minimum Order Quantity : 1530 Boxes
Recommended For : Treatment of Type 2 Diabetes Mellitus associated with dyslipidemia
Function : Other
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Drug Type : Specific Drug
Contact Details
- Plot No. 364, Industrial Area, Phase-1,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
